Crossmark

Efficacy of GLP-1 receptor agonists and dual GLP-1/GIP receptor agonists in managing MALFD: a meta-analysis of randomized controlled trials

Published Online: 2025-10-27

Authors

Tamilwanan, Surtika https://orcid.org/0009-0001-3003-5226
Aziz, Zoriah https://orcid.org/0000-0001-7113-9323
Rong, Lim Yan https://orcid.org/0009-0008-6090-6361
Bitar, Ahmad Naoras https://orcid.org/0000-0003-0125-2683
Zarzour, Raghdaa Hamdan Al https://orcid.org/0000-0002-9794-3552
Alshehade, Salah A. https://orcid.org/0000-0001-8732-1883
License Information

Text and Data Mining valid from 2025-10-27

Version of Record valid from 2025-10-27
More Information

Article History

Received: 14 May 2025

Accepted: 25 September 2025

First Online: 27 October 2025

Declarations

:

: Not applicable. This systematic review and meta-analysis utilized only previously published data from randomized controlled trials. No primary data collection involving human participants was conducted as part of this study.

: Not applicable. This manuscript does not contain any individual person’s data in any form.

: The authors declare no competing interests.

Document is current